Life Sciences sector focus
Specialist sectors
Practical transaction relevance
PMC focuses on markets where regulation, therapeutic context, channel access and strategic fit determine which opportunities and counterparties are genuinely relevant.
Sector knowledge as a decision tool
Broad enough for the market – specific enough for matching
PMC structures sector information around commercial and transaction logic. This helps distinguish a broad industry fit from a credible strategic fit – whether the task is to identify a buyer, originate a target, assess a product opportunity or find the right partner.
Core sector coverage
Six connected fields across Pharma, Healthcare and Life Sciences
The boundaries often overlap. PMC uses the relevant combination of product, technology, service, channel and geography rather than relying on a single industry label.
Products, pipelines and platforms
Specialty Pharma, Biotech platforms, Rx products, development assets, pipelines, licensing opportunities and strategic partnerships.
Devices, diagnostics and enabling technologies
Medical devices, point-of-care platforms, tools, equipment, laboratory infrastructure and technology-enabled Healthcare products.
Brands, nutrition and self-care
OTC brands, nutrition, metabolic health, pharmacy products, supplements, wellness portfolios and consumer Healthcare platforms.
Care, distribution and commercial platforms
Specialist clinics, care models, commercial service platforms, distribution, provider networks and Healthcare operations.
Development and manufacturing capabilities
Manufacturing, drug delivery, formulation, clinical research, regulatory affairs, laboratory services and outsourced development.
Technology supporting Life Sciences growth
Healthcare software, data platforms, market access tools, commercialisation services and specialist digital infrastructure.
From classification to relevance
What PMC examines within a sector
A sector name is only the starting point. Transaction relevance becomes clearer when the strategic, commercial and operational context is considered together.
Therapeutic and regulatory context
Indication, development or commercial stage, regulatory route, reimbursement and evidence requirements.
Product and business model
Rx, OTC, device, diagnostics, service, technology, manufacturing, licensing or distribution logic.
Geography and channel access
Market rights, regional presence, sales channels, prescriber or consumer access and expansion potential.
Strategic and financial fit
Scale, capabilities, portfolio logic, investment horizon, synergies and the likely transaction route.
Transaction scope
Sector expertise applied across different forms of value
PMC can work from a company, a product, a capability or a strategic objective. The transaction route follows the underlying value and the counterparties required to realise it.
View PMC services- 01
Products & intellectual property
Brands, dossiers, licences, technologies, development assets, pipelines and regional rights.
- 02
Companies & platforms
Standalone businesses, groups, subsidiaries, divisions, carve-outs and platform acquisitions.
- 03
Services & infrastructure
Development, manufacturing, clinical, regulatory, commercial, digital and distribution capabilities.
- 04
Partnerships & capital
In-licensing, out-licensing, commercial partnerships, minority investment, growth capital and exits.
Transaction themes
The same sector logic supports selling, acquiring and partnering
Sector context guides the counterparty universe, the information required and the most appropriate route to a qualified decision.
Company and platform transactions
Sales, acquisitions, divestments, subsidiaries, divisions, carve-outs and platform strategies.
Portfolio and asset transactions
Rx and OTC brands, portfolios, dossiers, licences, technologies, R&D projects and commercial rights.
Commercial and capital routes
Distribution, co-promotion, licensing, investment, growth capital and strategic partnerships.
A defined sector objective
Tell PMC where you want to grow, sell or invest
PMC will translate the sector context into a practical route for target search, buyer mapping, confidential opportunity review, licensing dialogue or mandate preparation.
